INMD - Get Into This Growth Stock for 2023 and Beyond
The stock of aesthetic surgical company InMode (NASDAQ: INMD) has fallen 66% from its high, underperforming the broader market over the past year. Investors are scratching their heads and wondering whether the market knows better or if there's a colossal misunderstanding here.
Bear markets often mean relentless selling, and Wall Street doesn't always get it right. The numbers show that InMode is more than just fine -- and the stock could be a market beater when growth stocks come back into favor with investors.
Picking winning stocks was almost too easy in 2021, when virtually every stock was soaring. But that gets snuffed out in a bear market. Some low-quality stocks will never see their highs again.
For further details see:
Get Into This Growth Stock for 2023 and Beyond